DEVELOPING A NOVEL PHARMACEUTICAL FORMULATION FOR IMPROVING PATIENT COMPLIANCE

Abstract

In order to create a final, usable pharmaceutical product, the active ingredient is combined with all other constituents in a multi-step procedure that takes pH, solubility, polymorphism, and particle size into consideration.    The formulation frequently works by mixing various dose forms.    The pharmaceutical drug product that is marketed for use with a certain combination of active and inactive ingredients is referred to as the dosage form.   It must be given in a certain dosage and have a certain form (capsule shell, for instance).   Tens of thousands of different drug formulations are already available for use by doctors and patients. It has taken a lot of time and money to produce each of these pharmacological formulations in order to comprehend how the medications function and evaluate their effectiveness.  Only a small percentage of the proteins in the human body are the targets of current pharmaceuticals, despite the fact that many of them are known to interact with them.   This makes it possible to create future drugs that specifically target the body's remaining proteins.